Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
Surfing the MASH Tsunami
S2 E18.1 -- How Does MR Elastography Help Identify NASH PAtients Who Are Likely To Progress?
Alina Allen shares the results of her recent Clinical Gastroenterology and Hepatology paper on predictive value of MR Elastography in determining likelihood of progress for NASH patients exhibiting F1 - F3 disease and separately, those living with cirrhosis.
Using a longitudinal data base of over 800 patients spanning 12 years, Dr. Allen and her colleagues published analysis demonstrated that kPa readings based on MR Elastography produced highly significant results predicting likelihood of progression. Alina shares some of the thinking that drove the desire to do the study and presents some of the key results. Louise Campbell and Roger Green ask clarifying questions from their own very distinct perspectives.